Efficacy of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease and obstructive sleep apnea; a randomized controlled trial
Journal of Rehabilitation Medicine · 2024
DOI: 10.2340/jrm.v56.23757 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Rehabilitation Medicine, 2024. Verfasst von Honghua Shen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Rehabilitation, the Fourth Rehabilitation Hospital of Shanghai, Shanghai, China; Department of Respiratory and Critical Car…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Sleep Apnea, Obstructive. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: COPD
Abstract (Originalsprache)
Objective
To evaluate the efficacy of pulmonary rehabilitation in the outcomes of patients with chronic obstructive pulmonary disease–obstructive sleep apnoea overlap syndrome patients who used positive airway pressure.
Design
Prospective randomized controlled single- blind trial. Patients: A total of 79 patients with chronic obstructive pulmonary disease–obstructive sleep apnoea overlap syndrome were randomly assigned to either the intervention group (n = 40) or control group (n = 39).
Methods
All patients consistently adhered to positive airway pressure therapy every night from enrolment in the study, while intervention group patients received additional moderate-intensity aerobic exercise for 20 weeks. Pre- and post-intervention measurements included the 6-Minute Walk Test, Barthel Index, body mass index, fat mass, free fat mass, forced expiratory volume in 1 s (FEV1), FEV1%predicted, modified Medical Research Council, and polysomnography parameters.
Results
After 20 weeks, the intervention group exhibited statistically significant improvements in 6MWD, Barthel Index, body mass index, fat mass, and modified Medical Research Council compared with control group (all p < 0.01). In addition, the intervention group showed a significantly lower percentage of total sleep time with oxygen saturation < 90% (p = 0.013) and higher lowest nocturnal oxygen saturation (p = 0.008) than the control group. However, there was no significant difference in FEV1 %predicted between the 2 groups.
Conclusion
Pulmonary rehabilitation incorporating moderate-intensity aerobic exercise could improve physical endurance and motor abilities in individuals with chronic obstructive pulmonary disease–obstructive sleep apnoea overlap syndrome, while also improving anamnestic dyspnoea, body composition, and sleep-disordered breathing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Respiratory Rehabilitation, the Fourth Rehabilitation Hospital of Shanghai, Shanghai, China; Department of Respiratory and Critical Care Medicine, Sleep Center, the Second Affiliated Hospital of Soochow Un…
- Department of Respiratory Rehabilitation, the Fourth Rehabilitation Hospital of Shanghai, Shanghai, China.
- Department of Respiratory and Critical Care Medicine, Sleep Center, the Second Affiliated Hospital of Soochow University, Suzhou, China. chenruigood@126.com.
Zitieren
APA
Shen, H., Xu, Y., Zhang, Y., Ren, L., & Chen, R. (2024). Efficacy of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease and obstructive sleep apnea; a randomized controlled trial. Journal of Rehabilitation Medicine. https://doi.org/10.2340/jrm.v56.23757
Vancouver
Shen H, Xu Y, Zhang Y, Ren L, Chen R. Efficacy of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease and obstructive sleep apnea; a randomized controlled trial. Journal of Rehabilitation Medicine. 2024. doi:10.2340/jrm.v56.23757
BibTeX
@article{Shen2024,
author = {Shen, Honghua and Xu, Yiming and Zhang, Yin and Ren, Lei and Chen, Rui},
title = {Efficacy of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease and obstructive sleep apnea; a randomized controlled trial},
journal = {Journal of Rehabilitation Medicine},
year = {2024},
doi = {10.2340/jrm.v56.23757}
}
EUVIMED